SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-453184
Filing Date
2013-11-25
Accepted
2013-11-25 17:25:57
Documents
7
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d608283d10q.htm 10-Q 503203
2 EX-10.27 d608283dex1027.htm EX-10.27 321423
3 EX-31.1 d608283dex311.htm EX-31.1 7417
4 EX-31.2 d608283dex312.htm EX-31.2 7408
5 EX-32.1 d608283dex321.htm EX-32.1 4486
6 GRAPHIC g608283exa_pg071.jpg GRAPHIC 92025
7 GRAPHIC g608283exa_pg074.jpg GRAPHIC 153004
  Complete submission text file 0001193125-13-453184.txt   1183003
Mailing Address 3876 BAY CENTER PLACE HAYWARD CA 94545
Business Address 3876 BAY CENTER PLACE HAYWARD CA 94545 510-293-8800
CymaBay Therapeutics, Inc. (Filer) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55021 | Film No.: 131241875
SIC: 2834 Pharmaceutical Preparations